NKTX
Nkarta, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.92
+4.66%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-47.4%
Return on equity
-34.7%
Return on assets
-41.2%
Return on invested capital
0.00x
Asset turnover
-$92.8M
Cash from operations
$2.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026